Brief: Masimo Announces Select Preliminary Full-Year 2019 Financial Results And 2020 Guidance

Nanthealth

14/01/2020 14:26

Jan 14 (Reuters) - Masimo Corp  MASI.O :
    * MASIMO ANNOUNCES SELECT PRELIMINARY FULL-YEAR 2019
FINANCIAL
RESULTS AND 2020 GUIDANCE
    * SEES FY 2020 REVENUE ABOUT $1.04 BILLION 
    * SEES PRELIMINARY FULL-YEAR 2019 TOTAL REVENUE, INCLUDING
ROYALTY
AND OTHER REVENUE, OF APPROXIMATELY $934 TO $937 MILLION
    * SEES PRELIMINARY FULL-YEAR 2019 PRODUCT REVENUE OF
APPROXIMATELY
$933 TO $936 MILLION
    * SEES FULL YEAR 2020 NON-GAAP EARNINGS PER DILUTED SHARE
$3.56
    * EXPECTS FULL-YEAR 2019 GAAP EARNINGS PER SHARE WILL EXCEED
PREVIOUSLY ISSUED FINANCIAL GUIDANCE OF $3.37 PER DILUTED SHARE
    * EXPECTS FULL-YEAR 2019 NON-GAAP EARNINGS PER SHARE WILL
EXCEED
PREVIOUSLY ISSUED FINANCIAL GUIDANCE OF $3.18 PER DILUTED SHARE
    * EXPECTS AGREEMENT TO ACQUIRE CONNECTED CARE ASSETS FROM
NANTHEALTH TO CONTRIBUTE ABOUT 1 PERCENT POINT TO ITS FY 2020
REVENUE GUIDANCE GROWTH RATE
    * COMPANY EXPECTS TRANSACTION WITH NANTHEALTH TO BE SLIGHTLY
DILUTIVE TO NON-GAAP EARNINGS PER SHARE IN 2020
    * EXPECTS TRANSACTION WITH NANTHEALTH TO BE ACCRETIVE TO
NON-GAAP
EARNINGS PER SHARE BEGINNING IN 2021
    * SEES FY 2020 GAAP EARNINGS PER DILUTED SHARE $3.64
    * FY2019 EARNINGS PER SHARE VIEW $3.18, REVENUE VIEW $933.5
MILLION -- REFINITIV IBES DATA
    * FY2020 EARNINGS PER SHARE VIEW $3.56, REVENUE VIEW $1.02
BILLION
-- REFINITIV IBES DATA

Source text for Eikon:  urn:newsml:reuters.com:*:nBw6hz611a
Further company coverage:  MASI.O 

 ((Reuters.Briefs@thomsonreuters.com;))